报告摘要：For more than three decades, RNA has been known as an attractive macromolecule target for therapeutic purposes, But the identification of the drug optimization and target validation that have led to the approval of a few RNA-targeting therapeutics for clinical applications remain challenging. The key factors accounting for these successes will be addressed. The crucial aspects worth considering ...

2023年5月23日上午9点，生命科学学院一楼北厅，中国科学院生物物理所薛愿超研究员作题为“非编码RNA与转录调控”的学术报告。

2023年5月13日晚18:30，生命科学学院一楼中厅，香港科技大学邬振国教授作题为“损伤后肌肉干细胞活化的调控机制”的学术报告。